what's the difference in tirzepatide and semaglutide vs Comparative safety and side effects

as an adjunct to standard of care therapy to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with established cardiovascular disease, with a BMI 27 kg/m 2 , and without established Type 1 or Type 2 diabetes

GLP-1 drugs reduce appetite, making weight loss feel easier

To stimulate its receptor, GLP-1 requires the presence of 2 N-terminal amino acids, which are cleaved by the enzyme, dipeptidyl peptidase-4 (DPP-4), rendering the truncated form (GLP-1-9,36) inactive

The MHRA has separately reported that counterfeit pens have been found to contain insulin or unidentified substances, which can cause life-threatening low blood sugar in people who dont have diabetes

2% among adults in England in 2022) [2] and women are more likely to seek and receive medical treatment for weight loss [24], so they may be prescribed these drugs at higher rates than men

It supports the body's own ability to regulate hunger, energy use, and fat storage from the inside outwithout overtaxing the nervous system